Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

Daruka Mahadevan, Amy Stejskal, Laurence S. Cooke, Ann Manziello, Carla Morales, Daniel O. Persky, Richard I. Fisher, Thomas P. Miller, Wenqing Qi

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences